Skip to main content

Table 8 The psychometric properties analyzed in mixed diagnosis studies

From: Comparison of content and psychometric properties for assessment tools used for brain tumor patients: a scoping review

Assessment instrument Reliability Validity Responsiveness Time Research group References
Test–retest Inter-rater Intra-rater Content Structural Criterion
EORTC QLQ- C30    +*   +     n = 89, myeloma Kontodimopoulos et al. [35]
   +*   +     n = 105, breast cancer Kontodimopoulos et al. [35]
   +*   +     n = 28, lung cancer Ozturk et al. [36]
   +*   + +    n112, lung cancer Nicklasson and Bergman [37]
   +   +    11 min n = 305, lung cancer Aaronson et al. [38]
FIM    +    +      n = 93,829, rehabilitation patients Stineman et al. [39]
  + +   +     n = 62, SCI; n = 51, stroke Küçükdeveci et al. [40]
+     +     n = 49, age > 50 Pollak et al. [41]
  +        n = 50, SCI Karamehmetoglu et al. [42]
  +        n = 11 studies Ottenbacher et al. [43]
   +   +   +   n = 11 102, mixed diagnosis Dodds et al. [44]
     + +    n = 1502, neurologic deficit Ng et al. [45]
     +     n = 102, acute stroke Tur et al. [46]
     +     n = 48, brain trauma Hall et al. [47]
       + 30–40 min n = 516, mixed diagnosis Coster et al. [48]
BI + + +   +     n = 459, stroke Oveisgharan et al. [49]
   +   +     n = 258, stroke Shah et al. [50]
  +   +    + 10.1 min (± 1.56) n = 50, neurologic deficit Rödén-Jüllig et al. [51]
   +   +     n = 90, multiple sclerosis Nicholl et al. [52]
  +        n = 273, neurologic deficit Rollnik [53]
      +    n = 75, brain trauma Liu et al. [54]
       +   n = 259, vascular brain damage; n = 107 brain trauma Houlden et al. [55]
SF-36 +   +   +     n = 1980, mixed Brazier et al. [56]
   +   +     n = 124, stroke Anderson et al. [57]
   +   +     n = 252, n-198, endometriosis Stull et al. [58]
+   +       n = 37, Parkinsons Steffen and Seney [59]
+         n = 209, stroke Dorman et al. [60]
   +       n = 514, brain trauma Guilfoyle et al. [61]
      +    n = 120, brain trauma Paniak et al. [62]
MMSE    +   +   +   n = 207, brain trauma Elhan et al. [63]
+     +    10 min n = 63, no impairments; n = 206, cognitive impairments Folstein et al. [64]
  +        n = 48, age > 50 Molloy et al. [65]
   +       n = 72, stroke Toglia et al. [66]
        n = 112, stroke Blake et al. [67]
KPS   +    +     n = 52, tumor Yates et al. [68]
  +     +    n = 100, mixed diagnosis Grieco et al. [69]
  +     +    n = 47, tumor Mor et al. [70]
  +     +    n = 93, tumor Schag et al. [71]
TMT +     +    A part 180 s
B part 300 s
n = 484, age > 50 Cangoz et al. [71]
    + +    n = 117, neurologic deficit O’Donnell et al. [72]
  1. For interpretation of “+” and “−” for each property: Internal reliability: “+” Cronbach’s ɑ or ICC ≥ 0.70; “−” Cronbach’s ɑ or ICC < 0.70;
  2. Test/retest method: “+” ICC ≥ 0.70 or Pearson correlation coefficient/ Spearman rank correlation coefficient ≥ 0.80; “−” ICC < 0.70 or Pearson correlation coefficient/Spearman rank correlation coefficient < 0.80;
  3. Interrater reliability: “+” ICC ≥ 0.70 or Pearson correlation coefficient/ Spearman rank correlation coefficient ≥ 0.80; “−” ICC < 0.70 or Pearson correlation coefficient/Spearman rank correlation coefficient < 0.80;
  4. Content validity: “+” The content of the assessment instrument is adequate, comprehensive, questions and tasks chosen to adequately reflect the content to be evaluated; “−” Not all selected questions and tasks reflect the content, content is not relevant, comprehensive;
  5. Criterion validity: “+” Significant and stable relation between measurement and another instrument (r ≥ 0.70) or with start/end measurement; “−” Poor measurement correlation with another instrument (r < 0.70) or start / end measurement;
  6. Structural validity: “+” Correlation with instruments measuring the same ≥ 0.50 or correlation higher for unrelated elements in the instrument than for unrelated ones; “−” Correlation with instruments measuring the same < 0.50 or correlation with related elements in the instrument is lower than unrelated ones;
  7. Responsiveness: “+” Able to detect clinically significant changes over time; “−” Cannot detect clinically significant changes over time
  8. *Except Cognitive scale